null

Ulocuplumab Biosimilar (Anti-CXCR4) Antibody (HDBS0089)

SKU:
HDBS0089
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Protein:
CXCR4
Reactivity:
Human
Host Species:
Chimeric Humanized
Isotype:
IgG4
$479

Description

system_update_altDatasheet

Ulocuplumab (Anti-CXCR4) Biosimilar Antibody (HDBS0089)

The Ulocuplumab Biosimilar Anti-CXCR4 Antibody is a cutting-edge product designed for research involving the CXCR4 protein, a key player in cell migration and cancer metastasis. This biosimilar antibody, developed through advanced technology, exhibits high specificity and affinity for the CXCR4 molecule, allowing for accurate detection and analysis in various experimental settings.CXCR4, a chemokine receptor, is known to play a critical role in tumor growth, angiogenesis, and metastasis in various types of cancer. By targeting CXCR4 with this antibody, researchers can explore its mechanisms of action in cancer progression and potentially develop novel therapies to combat metastatic disease.

The Ulocuplumab Biosimilar Anti-CXCR4 Antibody offers a reliable tool for investigating the role of CXCR4 in cancer biology and identifying potential therapeutic targets for anti-cancer treatments. With its proven effectiveness in research studies, this antibody is a valuable asset for scientists and researchers working in the fields of oncology and cancer biology.